It inhibits pro-tumorigenic signals such as PI3K/Akt/mTOR and NF-κB, while activating tumor-suppressive pathways like AMPK, forming an intricate regulatory network that highlights its unique advantages and tremendous potential as a natural multi-target metabolic modulator. The gene discussed is MTOR; the disease is neoplasm.